The next REVIVE webinars will be announced soon

Upcoming webinars and recordings of previous REVIVE webinars are available here:

Educational webinars on topics related to antimicrobial drug discovery and development

The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study — 9 July 2020
The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study
more

Clinical development of antimicrobials – Phase 1 development challenges — 30 June 2020
Clinical development of antimicrobials – Phase 1 development challenges
more

Test tube to patient: PK/PD of fixed dose beta-lactam/beta-lactamase inhibitor combinations — 9 June 2020
Test tube to patient: PK/PD of fixed dose beta-lactam/beta-lactamase inhibitor combinations
more

Assay development for measuring antibiotic accumulation in Gram-negative bacteria — 19 May 2020
Assay development for measuring antibiotic accumulation in Gram-negative bacteria
more

Probability of target attainment analyses for dose selection in antimicrobial drug development — 12 May 2020
Probability of target attainment analyses for dose selection in antimicrobial drug development
more

Inhaled antimicrobials: Do we get the drug to the bug? — 28 April 2020
Inhaled antimicrobials: Do we get the drug to the bug?
more

PK/PD murine infection models: Focus on study elements, variability, and interpretation of results — 27 February 2020
PK/PD murine infection models: Focus on study elements, variability, and interpretation of results
more

Non-traditional antibacterial therapeutic options and challenges — 4 February 2020
Non-traditional antibacterial therapeutic options and challenges
more

Testing for the potential of emergence of antimicrobial resistance — 21 January 2020
Testing for the potential of emergence of antimicrobial resistance
more

Innovation in point-of-care diagnostics for sepsis and bloodstream infections — 26 November 2019
Innovation in point-of-care diagnostics for sepsis and bloodstream infections
more

Converting Gram-positive-only compounds into broad-spectrum antibiotics — 7 November 2019
Converting Gram-positive-only compounds into broad-spectrum antibiotics
more

Natural product antibiotics: from traditional screening to novel discovery approaches — 3 October 2019
Natural product antibiotics: from traditional screening to novel discovery approaches
more